Afinitor (everolimus) is a prescription drug that’s used to treat some types of cancer, seizures, and certain tumors. This drug can interact with other medications and some supplements. For ...

Patients with previously treated advanced clear cell renal cell carcinoma (RCC) — a type of kidney cancer — experienced improvements in progression and response via treatment with Welireg (belzutifan) ...

The best pill organizers help me stay on track and make travel a breeze, ensuring everything is secure and in its place. Like its contents, pill cases come in all different shapes and sizes ...

At least nine died, said Damian Williams, the U.S. attorney in Manhattan. “The pills were filled with poison,” Mr. Williams said during a news briefing on Monday. “They injured and killed ...

Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation ...

The pill is made by Novo Nordisk, the same company that makes Ozempic. The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

There is a new chapter in Big Pharma’s billion-dollar war on obesity, as Novo Nordisk and Eli Lilly battle it out over the latest blockbuster drugs. Ozempic maker Novo Nordisk’s highly ...

So we finally got a rate cut — and a supersized one at that. After the move was announced Wednesday, Federal Reserve Chair Jerome Powell said officials made that decision to keep the US economy ...

Both of these certainly contribute to Bloom’s metamorphosis, as his cauliflower ear and the nicks in his buzz-cut hair and above his eyebrow tell their own story about the punishment he’s taken.

An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo ...

Ozempic maker Novo Nordisk says its highly anticipated experimental weight-loss pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.